CHEMOTHERAPY-INDUCED ANEMIA MANAGEMENT WITH DARBEPOETIN ALFA IN DAILY CLINICAL PRACTICE

被引：0
|
作者：
Cruz, M. A. [1 ]
Bustos, A. [2 ]
Carabantes, F. [3 ]
Diaz, N. [4 ]
Rovira, P. Sanchez [5 ]
Froilan, J. [6 ]
Lorenzo, I. [7 ]
Gasquet, J. A. [7 ]
Alegre, A. [8 ]
机构：
[1] Hosp Virgen Salud, Toledo, Spain
[2] Clin Vistahermosa, Alicante, Spain
[3] Hosp Carlos Haya, Malaga, Spain
[4] Hosp San Juan Alicante, Alicante, Spain
[5] Hosp Jaen, Jaen, Spain
[6] Hosp Barbastro, Barbastro, Spain
[7] Amgen Inc, Barcelona, Spain
[8] Hosp Princesa, Madrid, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [1] Chemotherapy-induced anemia: the story of darbepoetin alfa
    Vansteenkiste, Johan
    Wauters, Isabelle
    Elliott, Steven
    Glaspy, John
    Hedenus, Michael
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (04) : 325 - 337
  • [2] Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice
    Patton, J
    Reeves, T
    Wallace, J
    ONCOLOGIST, 2004, 9 (04): : 451 - 458
  • [3] Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Herrington, JD
    Davidson, SL
    Tomita, DK
    Green, L
    Smith, RE
    Boccia, RV
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (01) : 54 - 62
  • [4] Evaluation of clinical use of darbepoetin alfa in patients with chemotherapy-induced anemia
    Bustos, A.
    Cruz, M. A.
    Aramburo, P.
    Carabantes, F.
    Diaz, N.
    Florian, J.
    Lazaro, M.
    Martin de Segovia, J. M.
    Gasquet, J. A.
    Alegre, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia
    Bloomfield, M
    Jaresko, G
    Zarek, J
    Dozier, N
    PHARMACOTHERAPY, 2003, 23 (12): : 110S - 118S
  • [6] Therapeutic interchange of darbepoetin alfa for epoetin alfa for chemotherapy-induced anemia.
    Blamble, DA
    Shermock, KM
    Nesbit, TW
    Pinto, B
    Fetting, J
    PHARMACOTHERAPY, 2004, 24 (10): : 1477 - 1477
  • [7] A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia
    Schwartzberg, L
    Shiffman, R
    Tomita, D
    Stolshek, B
    Rossi, G
    Adamson, R
    CLINICAL THERAPEUTICS, 2003, 25 (11) : 2781 - 2796
  • [8] A PROSPECTIVE DATA AUDIT OF THE MANAGEMENT OF CHEMOTHERAPY-INDUCED ANEMIA WITH DARBEPOETIN ALFA - THE APRIORI STUDY
    Boguradzki, P.
    Boer, K.
    Cipkova, A.
    Wojciechowska-Lampka, E.
    Schuetzova, M.
    Ocvirk, J.
    Toth, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 504 - 504
  • [9] Epoetin Alfa and Darbepoetin Alfa in Clinical Practice in Patients With Chemotherapy Induced Anemia in the Netherlands (EVALUATE)
    van Groeningen, C. J.
    Kok, T. C.
    Biesma, B.
    Melissant, C. F.
    de Klerk, G.
    Brok, R. G. P. M.
    Lahaye, M.
    Milek, R. L. B.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S237 - S237
  • [10] Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia
    Bustos, Aurelia
    Alvarez, Ruth
    Miguel Aramburo, Pedro
    Carabantes, Francisco
    Diaz, Nieves
    Florian, Jesus
    Lazaro, Martin
    Maria Martin de Segovia, Jose
    Antonio Gasquet, Jose
    Alegre, Adrian
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (01) : 57 - 67
12345